in situ hybridization, and radioligand binding using the novel high-affinity (Kd 22 PM) ligand
[3H]iberiotoxin-D1 9C ([3H]lbTX-D1 9C), which is an analog of the selective maxi-K peptidyl blocker IbTX. A sequence-directed antibody directed against S/o revealed the expression of a 125 kDa polypeptide in rat brain by Western blotting and precipitated the specifically bound [3H]lbTX-D1 9C in solubilized brain membranes.
S/o immunoreactivity was highly concentrated in terminal areas of prominent fiber tracts: the substantia nigra pars reticulata, globus pallidus, olfactory system, interpeduncular nucleus, hippocampal formation including mossy fibers and perforant path terminals, medial forebrain bundle and pyramidal tract, as well as cerebellar Purkinje cells. In situ hybridization indicated high levels of S/o mRNA in the neocortex, olfactory system, habenula, striatum, granule and pyramidal cell layer of the hippocampus, and Purkinje cells. The distribution of S/o protein was confirmed in microdissected brain areas by Western blotting and radioligand-binding studies. The latter studies also established the pharmacological profile of neuronal S/o channels. The expression pattern of S/o is consistent with its targeting into a presynaptic compartment, which implies an important role in neural transmission.
Key words: maxi-K channel; distribution; expression; pharmacology; iberiotoxin; antibodies; in situ hybridization; immunocytochemistry Ion channels play key roles in translating ionic fluxes across cellular membranes into electrical impulses through their ability to interconvert electrical signals. K' channels represent the largest and most diverse group of ion channels and are present in essentially every neuronal cell type (Latorre et al., 1989) . They can be subdivided into voltage-gated K+ and Ca'+-activated K' channels. Two major classes of Ca'+-activated Kf channels have been identified in the CNS: (1) voltage-sensitive high-conductance (maxi-K) channels, most of which are blocked by charybdotoxin (ChTX) and iberiotoxin (IbTX) (Miller et al., 1985; Galvez et al., 1990) ; and (2) voltage-insensitive small-conductance channels, many of which are blocked by apamin (Lancaster et al., 1991) .
The maxi-K channel has been purified from bovine tracheal smooth muscle (Garcia-Calvo et al., 1994) and is composed of two distinct subunits, (Y and /3, (Knaus et al., 1994a) . The cy subunit is a member of the Slo family of K+ channels, whereas the p subunit is a novel protein that has pronounced effects on the biophysical (McManus et al., 1995) . Cloning of Slo channels from neuronal tissues has suggested the existence of a large number of channel isoforms (Butler et al., 1993; Tseng-Crank et al., 1994) . This diversity is generated by alternative RNA splicing of a single gene (Butler et al., 1993; Dworetzky et al., 1994; Pallanck and Ganetzky, 1994) . Alternatively spliced constructs differ significantly in their biophysical properties (Adelman et al., 1992; Tseng-Crank et al., 1994; Wei et al., 1994) . Thus, alternative RNA splicing, opposite regulation via phosphorylation by various protein kinases, and perhaps association with other accessory subunits could contribute to the diversity of Slo channels in mammalian brain (Reinhart et al., 1989 (Reinhart et al., , 1991 Tseng-Crank et al., 1994) . The functional role of Slo channels in the mammalian brain is not well understood. Their putative colocalization with voltage-gated Ca*' channels suggests that they function as feedback regulators of intracellular Ca'+ concentration by hyperpolarizing the plasma membrane (Robitaille and Charlton, 1992) . In some neurons, this may allow Slo channels to regulate the amount of neurotransmitter released from presynaptic nerve terminals by modulating the duration of the presynaptic action potential (Robitaille et al., 1993) . Additionally, these channels can also contribute to firing patterns (MacDermott and Weight, 1982) and afterhyperpolarization in certain neurons (Lancaster and Nicoll, 1987) .
To obtain a better understanding of the functional role of this channel, dctailcd knowledge regarding its rcgional distribution and cytological localization is required. Ajinity purification of anti-+,,.,.,,,, and immunohlot ana!y.sis. The peptide VNDTNVOFLDODDD (2 umol) was dissolved in 100 mM NaHCO, buffer, pH 8.5, and incubated'with 1 irn of cyanogen bromide-activate2 Sepharose (4 ml of packed gel) for 12 hr at 4°C. The coupling efficiency was monitored by determining the absorbance at 215 nm before and after coupling. Thereafter, the affinity matrix was washed alternately with (500 ml each) 50 mM ammonium acetate, pH 4.0, and 50 mM Tris-HCI, pH 8.5, and equilibrated with 20 mM Tris-HCI, pH 7.4, and 150 mM NaCl (TBS). Crude serum (3 ml) was incubated under gentle rotation with the affinity matrix for 12-15 hr at 4°C. After unbound material was collected and the gel was washed with TBS, antibodies were eluted within 5 min with either 100 mM glycine buffer, pH 2.5, or 5 M MgCIZ.
The glycine buffer was neutralized immediately with 2 M Tris base, and the MgCI, eluate was diluted fivefold with ice-cold TBS and 1 mgiml bovine serum albumin (BSA) and washed several times with ice-cold TBS in a Centricondevice (Amicon, Beverly, MA). The overall recovery, as determined by ELISA, was usually 20-400/o. The antibody aliquots were stored at -20°C in 20 mM Tris-HCI, pH 7.4, 150 mM NaCI, and 0.02% NaN,, without any loss in activity.
Immunoblot analysis, in vitro translation of S/o, and immunoprecipitation studies were performed as described in detail in Knaus et al. (1995) .
InlmLlr2ocyfochemisty. Male Sprague-Dawley rats (300-500 gm) were injected with a lethal dose of thiopcntal (150 mg/kg, i.p.). Their brains were perfused via the ascending aorta with 50 ml of ice-cold saline ((1.9%) buffered with 50 mM phosphate, pH 7.4, followed by 250 ml of chilled 4% p-formaldehyde in PBS (as above). After dissection, the brains were blocked into three parts, post-fixed for 90 min in the same fixative, transferred to 20% sucrose in PBS, and kept there for 24 hr (both at 4°C). Thereafter, brains were flash-frozen in isopentane (~70°C) for 3 min. The brains were kept in air-tight vials at -70°C. Before use, the brains were cut into 40 pm sections.
The indirect peroxidase-antiperoxidase technique (Sternberger, 1979) was used with free-floating slices, as described previously (Marksteiner et al., 1992) . In brief, sections were incubated 72-96 hr in 50 mM Tris-HCI, pH 7.4,0.85% NaCI, 0.4% Triton X-100, 0.1% NaN,, 2% ovalbumin, and 2% normal goat serum with affinity-purified an&+,,_,zh) to a dilution of 1:3000 of the original serum. Immunoreaction products were visualized by coupling with rabbit peroxidase-antiperoxidase via goat anti-rabbit the control experiments showed no specific hybridization signals (data not shown). In situ hybridizations were performed according to Wisden et al. (1990) . Probes were labeled at the 3' ends with terminal desoxynucleotidyl transferase and [a-Z'P]dATP (1000-3000 Ciimmol) to a specific activity of 10" dpmipg. Unincorporated nucleotides were removed by quick-spin columns. For in situ hybridization, brains were obtained from nonperfused rats and rapidly frozen on dry ice. Sections (16 km) were cut on a cryostat, thaw-mounted onto silane-coated slides, air-dried, and fixed in 4%~ p-formaldehyde.
After washing in PBS, sections were dehydrated and stored under ethanol at 4°C. Labeled probes were dissolved in hyhridization buffer (5000 dpmipl) and then applied to the air-dried sections. Hyhridization buffer contained 50%~ formamide, 10%) dextran sulfate, 0.3 M NaCI, 30 mM Tris-HCI, pH 7.7, 4 mM EDTA, 5 X Denhardt's solution, 25 mM dithiothreitol (DTT), 0.5 mg/ml yeast tRNA, and 0.5 mg/ml denatured salmon sperm DNA. The hybridizations were performed ovcrnight at 42°C. Sections were washed to a final stringency of I X SSC at 58°C. dehydrated, and exposed to Hyperfilm pmax for 3 weeks. Some sections were dipped into Kodak NTB2 nuclear track emulsion, exposed for 6 weeks at 4"C, developed with Kodak D19 developer, and counterstained with cresyl violet. Brain structures were identified using a hrain atlas (Paxinos and Watson, 1986 by Coomassie staining of SDS-PAGE gels, combined, and dialyzed overnight against 20 mM Tris-HCI, 100 mM NaCI, and 0.5 mM P-mercaptoethanol, pH 8.3. CaCl, was then added to a final concentration of 3 mM, and 1 wg of Factor Xa was added per milligram of fusion protein.
The mixture was incubated at room temperature for 18 hr, dialyzed against 20 mM sodium borate, pH 9.0, and loaded onto a Mono-S HRlO/lO cation-exchange chromatography column (Pharmacia) equilibrated with 20 mM sodium borate, pH 9.0. Elution of bound material was achieved in the presence of a linear gradient of NaCl (O-500 mM NaCI, 60 min) at a flow rate of 2 mlimin.
The fraction containing rccomhinant IbTX-DIYC was identified by N-terminal sequencing and incubated with 5% acetic acid at 45°C for 48 hr. This incubation time was required to achieve full cyclization of the N-terminal residue. Then the sample was applied to a C,, reversed-phase HPLC column, and elution was carried out using conditions similar to those reported previously for native IbTX (Galvez et al., 1990 experiments were computer-fitted to the general dose-response equation (DeLean et al., 1978) and then analyzed by a method described previously (Linden, 1982 
RESULTS

Characterization of a S/o-specific antibody in immunoblot analysis of rat brain
Anti-+,,3-YZh), a sequence-directed antibody directed against the pore-forming (Y subunit of the maxi-K channel, also referred to as Slo, was applied to investigate the presence and apparent molecular weight of the tissue-expressed gene product of Slo. Antic+,~-~~~) specifically recognized the in vitro translated Slo protein in immunoprecipitation assays (Fig. L4, lanes a and b) . More important, this antibody stained a singular diffuse band in rat brain membranes, which probably consisted of multiple partially resolved components, with an overall molecular mass of 125 kDa (Fig. lA, lanes c and f, B) . In immunoblotting experiments using membranes derived from different brain regions, the highest levels of Slo immunoreactivity were found in substantia nigra and the hippocampal formation (Fig. lB, lanes c andfl. High levels of Slo protein were also detected in the frontal cortex, olfactory tubercle, striatum, globus pallidus, and cerebellum (Figs. lA, lanes c andf,  2) . Significantly lower channel levels were seen in the brain stem and the spinal cord. completely abolished in the presence of 1 PM immunogenic peptide (Fig. 1, lanes d and e) .
Quantification of S/o expression in rat brain
To quantify levels of tissue expression in mammalian brain and to investigate the pharmacological characteristics of maxi-K channels, we synthesized ["H]IbTX-D19C, an analog of the maxi-K channel-selective peptidyl inhibitor IbTX. This ligand was characterized in binding studies with rat brain synaptic plasma membrane vesicles (Fig. 2) . In this system, ["H]IbTX-D19C binds to a single class of sites that displays a Kd of 22 PM with a maximum density of 0.13 pmol/mg protein (Fig. 2~2) binding at concentrations up to 10 nM (Fig. 2b) .
To quantify levels of maxi-K channel expression in individual brain regions, binding of [3H]IbTX-D19C was carried out with synaptic plasma membrane vesicles prepared from defined regions after rat brains were microdissected.
Results from these experiments are presented in to a significant extent and in a dosedependent manner by either crude anti-a(,,3-,-,,r serum (Fig. 2C ) or the affinity-purified antibody (data not shown).
Regional distribution of S/o immunoreactivity and mRNA in rat brain Given the high specificity of anti-a (,,,-,,,, for Sfo channels, the neuronal distribution pattern of these channels was investigated by parallel immunocytochemical analysis using this antibody and irr situ hybridization studies. The results of these experiments are shown in Figures 3-5 . In all instances, excess of immunogenic peptide completely abolished the staining reaction (data not shown). Slo immunoreactivity was found in individual somata and was also distributed diffusely in various brain regions. In all cases, the Slo immunostaining pattern revealed typical anatomical patterns, which most likely reflect staining of neuronal fibers. The most intense immunoreactive staining was observed in target areas of defined fiber tracts, whereas individual immunoreactive fibers were identified only occasionally. Slo immunoreactivity was negligible in major white matter tracts (e.g., corpus callosum) and in glial cells.
S/o expression
in the neocot-tex Within the neocortex, the Slo antibody reveals staining of the neutropil in all regions and throughout the entire thickness of the cerebral cortex, although immunoreactivity was especially enriched in layers II and VI (Fig. 3a,h) , which is where most of the S/o-positive neurons exhibit a shape and size typical for pyramidal neurons. This distribution correlates well with in situ hybridization data, which reveal high Slo mRNA levels in the neocortex, with particularly dense signals overlaying large cell bodies (presumably pyramidal cells). In accordance with these in situ hybridization results, prominent Slo immunoreactivity was present along the pyramidal tract in the brain stem, the major fiber system arising from pyramidal neurons of the cortex (Fig. Sg) . Among other major projection areas of the neocortex, diffuse Slo immunoreactivity was detected in the neocortex itself, the striatum, the pontine nuclei (Fig. 5d, arrow) , and the thalamic nuclei (Figs. 3u,h,  4a,h ).
S/o expression in the hippocampus High levels of 90 protein and mRNA are expressed in the hippocampal formation (Figs. 3a, 4u-c) , which is consistent with previous electrophysiological data ( Lancaster and Nicoll, 1987; Lancaster et al., 1991) . Slo mRNA is highly concentrated in all principal neurons of the hippocampal formation. The corresponding protein is found partly within the same cell layers but is mostly targeted to the axonal compartment of these neurons. Slo immunoreactivity is expressed strongly in mossy fibers, which represent the axons of granule cells innervating CA3 pyramidal neurons. (Fig. 4~) . Moreover, hippocampal Slo expression is observed in the middle and outer parts of the molecular layer, which suggests that the protein is contained within fibers of the perforant path terminating in this region of hippocampal formation. This fiber tract represents the major excitatory projection innervating the hippocampus. It originates from the entorhinal cortex in which high mRNA concentrations are detected. The presence of Slo immunoreactivity within the target areas of these hippocampal projections, in conjunction with the expression of Slo mRNA within CA3 and CA1 pyramidal neurons, suggests that maxi-K channels participate in major afferent, intrinsic, and efferent projections of the hippocampus. These neurons comprise an excitatory circuit of important physiological relevance, including longterm potentiation (Zalutsky and Nicoll, 1990; Madison et al., 1991) , and are causally involved in the generation of temporal lobe epilepsy (Meldrum and Corsellis, 1984) .
S/o expression in the olfactory system Slo mRNA is found in perikarya of the primary olfactory sensory neurons in the nasal cavity (data not shown). The axons of these neurons enter the olfactory bulb surface through the olfactory nerve layer and terminate in the glomerular layer in regions of neutropil called "glomeruli." Both layers are strongly stained with the Slo antibody (Fig. 4d) . Within the olfactory bulb, strong in situ hybridization signals are found overlaying mitral and granule cells located in the respective cell layers in the depths of the olfactory bulb (Figs. 3a, 4b ). Some Slo immunoreactivity is associated here with mitral and granule cell somata, an observation that is in accordance with the electrophysiological demonstration of Slo channels on cell bodies of olfactory bulb neurons (Egan et al., 1993) .
The dendrites of mitral cells, the secondary olfactory sensory neuron, traverse the external plexiform layer to terminate within the superficially located glomeruli, thereby forming axo-dendritic contacts with the primary olfactory axon. The external plexiform layer, which contains dendrites of mitral and granule cells exclusively, is essentially devoid of Slo immunoreactivity. In striking contrast, the central olfactory bulb layers (the mitral cell, the inner plexiform, and the granule cell layer) express high levels of Slo immunoreactivity. There the axons of mitral cells proceed into the very center of the olfactory bulb to reach their target areas in the olfactory cortex, which is also highly immunoreactive (data not shown). In summary, the axonal and presynaptic compartments of the primary and secondary olfactory sensory neurons express high levels of SZo channels, whereas the external plexiform layer, an exclusively dendritic compartment, is devoid of Slo immunoreactivity.
S/o expression in the extrapyramidal system Within the basal ganglia, Slo immunoreactivity is concentrated in three closely related structures: the globus pallidus, the substantia nigra pars reticulata, and the entopeducular nucleus. The corresponding mRNA is not found in these regions, however, but is concentrated instead over the striatum (Fig. 3a) , a brain region that contributes dense projections to the globus pallidus (Fig. 4e) , the substantia nigra pars reticulata (Figs. 4f, 5Li) , and the entopcducular nucleus (Fig. 4h) (Heimer et al., 1995) . In contrast, the substantia nigra pars compacta (which gives rise to dopaminergic neurons projecting to the striatum) is devoid of Slo immunoreactivity and mRNA (Fig. 4~9 . The most likely explanation for this illustrative anatomical distribution of Slo channels within the basal ganglia is that the Slo protein is being synthesized in projecting neurons within the striatum but is subsequently transported down their axons to be concentrated in nerve terminals of the respective fiber tracts. In accordance with these data, a high level of Slo immunoreactivity is detected in a major neuroanatomically well defined fiber tract connecting some of these brain regions, the media1 forebrain bundle (Fig. 4g) .
S/o expression in the habenula and interpeduncular nucleus Among the regions with the highest concentration of Slo mRNA is the medial habenula (Figs. 4u, arrow, 5a ), but only low levels of the corresponding protein can be detected in this nucleus. Slo immunoreactivity is observed along the entire fasciculus retroflexus (Fig. 5c) , however, and is heavily concentrated in the target area of this fiber tract, the interpeduncular nucleus (Figs.   5b,c) . Taken together, these results of parallel immunocytochemistry and in situ hybridization provide compelling evidence that SZo is translated in neuronal somata (in which its mRNA is localized), but the protein is subsequently targeted to axons and their terminals.
S/o expression in the cerebellum In the cerebellum, Slo mRNA is especially enriched in Purkinje cells and is found to a minor extent in the deep half of the molecular layer (mRNA: Figs. 3~7, 46, Sf; protein: Figs. 3b, 5e) . In contrast to most other brain regions in which Slo channels are targeted into the axonal compartment, Purkinje cells show Slo protein expressed in their cell bodies and proximal dendritic trunk. To rule out the possibility that Slo channels are located in parallel with the voltage-gated Kt channels Kvl.1 and Kv1.2 (McNamara et al., 1993; Sheng et al., 1994; Wang et al., 1994) in pinceau terminals (which are the axon collaterals of basket cells wrapping around the axon hillocks and initial axon segments of Purkinje cells), parallel sections were stained with a Kvl.2-specific antibody (data not shown). These experiments enabled us to assign Slo immunoreactivity predominantly to Purkinje cell somata, whereas the Kv1.2 antibody revealed impressive staining of pinceau terminals and spared Purkinje cell somata. This is the only instance in which we observed Slo immunoreactivity mainly in a postsynaptic compartment.
In addition to Slo immunoreactivity in Purkinje cell somata, significant amounts of Slo immunoreactive protein (Figs. 36, 5h) are contained in the deep cerebellar nuclei (which are a major projection area of the Purkinje cell axon). This could indicate that at least some Purkinje cell Slo channels are targeted into a presynaptic compartment (the deep cerebellar nuclei), whereas most of the Slo immunoreactivity seems to remain in the Purkinje cell somata, a localization of the channel that should be considered postsynaptic.
DISCUSSION
The distribution of the pore-forming cx subunit of the maxi-K channel Slo has been determined by immunocytochemistry and in situ hybridization in rat brain. For this purpose, a sequencedirected antibody (anti-c+,,-,,,)) g a ainst a putative extracellular linker connecting two hydrophobic sequence stretches (S9 and SlO) was raised. This antibody was designed to recognize all splice variants of Slo that have been described so far (Butler et al., 1993; Dworetzky et al., 1994; Pallanck and Ganetzky, 1994; TsengCrank et al., 1994) . The specificity of this antibody was assessed in immunoblot experiments using membranes derived from microdissected brain areas. The Slo polypeptide is expressed in various brain regions as a diffuse staining protein of 125 kDa, probably consisting of multiple partially resolved components. The M, of Slo in brain membranes is comparable with that obtained in other tissues that express Slo channels (bovine aorta and trachea and guinea-pig uterus) (Knaus et al., 1995) . Taken together, these results provide compelling evidence that the 125 kDa polypeptide recognized by anti-c+,,,-,,,) represents the gene product of Slo in rat brain, and they indicate that this antibody is a specific tool for studying Slo channels in brain tissue.
Despite the fact that ['251]ChTX has been used to identify maxi-K channels in different smooth muscle tissues (Vkquez et al., 1989) and that it has served as a marker for channel purification (GarciaCalvo et al., 1994) , the characterization of maxi-K channels in brain tissue with this ligand has not been possible. The reason for this could be related to a relatively low density of maxi-K channels as compared with voltage-gated K+ channels to which ['251]ChTX binds with high affinity (Schweitz et al., 1989; Vtiquez et al., 1990) . Because IbTX is a selective blocker of maxi-K channels without affecting other ChTXsensitive K' channels (Galvez et al., 1990) , we synthesized an IbTX analog IbTX-D19C, which was radiolabeled at position C~S'~ with N-[3H]ethylmaleimide. lbTX and IbTX-D19C block bilayerreconstituted maxi-K channels with similar affinities and kinetics (0. McManus, personal communication). Thus, [3H]IbTX-D19C enabled us to investigate directly, for the first time, neuronal maxi-K channels in radioligand binding studies and to establish their pharmacological characteristics. The expression of maxi-K channels in various brain regions, as quantitated in radioligand binding studies with [3H]IbTX-D19C, was correlated closely with Slo expression levels determined by Western blotting. This prompted us to investigate the distribution of Slo immunoreactivity by immunocytochemistry and to determine the corresponding mRNA levels by in situ hybridization.
Anatomical and functional implications of distribution of neuronal S/o channels Our study suggests a widespread distribution of Slo-immunoreactive perikarya and fibers as well as Slo mRNA in rat brain. The most
